Natus Medical (BABY) Misses Q4 EPS by 12c, Miss on Revenues; Offers FY18 EPS/Revenue Guidance Below Consensus

Natus Medical (NASDAQ: BABY) reported Q4 EPS of $0.42, $0.12 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $131.4 million versus the consensus estimate of $136.1 million.

• Reports record fourth quarter revenue of $131.4 million and full year revenue of $501.0 million
• Reports fourth quarter GAAP earnings (loss) per share of $(0.22) and non-GAAP of $0.42

Financial Guidance

For the first quarter of 2018, the Company provided revenue guidance of $125.0 million to $127.0 million and non-GAAP earnings per share guidance of $0.23 to $0.24.

For the full year 2018, the Company provided revenue guidance of $535.0 million to $540.0 million and non-GAAP earnings per share to $1.60 to $1.65.

The Company's non-GAAP earnings per share guidance excludes charges for amortization expense associated with intangible assets from prior acquisitions, which the Company expects to be approximately $6.8 million and $27.0 million for the first quarter 2018 and full year, respectively, and which the Company expects will reduce GAAP earnings per share by approximately $0.21 and $0.82 for the respective periods. Non-GAAP earnings per share also excludes the inventory FMV step-up of $2.6 million related to the Integra acquisition that is required for purchase accounting.

GUIDANCE:

Natus Medical sees FY2018 EPS of $1.60-$1.65, versus the consensus of $1.77. Natus Medical sees FY2018 revenue of $535-540 million, versus the consensus of $541.65 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c